Cas:344774-05-6 4-methylbenzenesulfonate,methyl-tris(2-methylpropyl)phosphanium manufacturer & supplier

Chemical Name:4-methylbenzenesulfonate,methyl-tris(2-methylpropyl)phosphanium

CAS.NO:344774-05-6

Synonyms:tri(isobutyl)methylphosphonium tosylate;MFCD04117693;tri-i-butyl(methyl)phosphonium tosylate;i-Bu3PMe TosO;[iBu3MeP][Tos];Methyltriisobutylphosphonium tosylate;MeP(i-Bu3)3 TosO

Molecular Formula:C₂₀H₃₇O₃PS

Molecular Weight:388.54500

HS Code:2931900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.075 g/mL at 20ºC(lit.)

Index of Refraction:

PSA:79.17000

Exact Mass:388.22000

LogP:6.58170

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3265 8/PG 2

Packing Group:

Contact us for information like tri(isobutyl)methylphosphonium tosylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MeP(i-Bu3)3 TosO physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tri-i-butyl(methyl)phosphonium tosylate Use and application,Methyltriisobutylphosphonium tosylate technical grade,usp/ep/jp grade.

Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 4-methylbenzenesulfonate,methyl-tris(2-methylpropyl)phosphanium manufacturer Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. 4-methylbenzenesulfonate,methyl-tris(2-methylpropyl)phosphanium supplier Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 4-methylbenzenesulfonate,methyl-tris(2-methylpropyl)phosphanium vendor Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. 4-methylbenzenesulfonate,methyl-tris(2-methylpropyl)phosphanium factory Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.